Medacta Group SA
Net SellingXSWX·XSWX·🇨🇭 CH
37%buys·63%sales
27 transactions$2.2MTotal buys·10 buys
$7.0MTotal sells·17 sells
11 insider
Last: Mar 23, 2026
Medacta Group SA (Medacta Group SA) has recorded 27 insider transactions from 1 insiders. Total insider buying volume stands at $2.2M, while total selling volume is $7.0M. Overall insider sentiment is bearish (63% sales).
Medacta Group SA (Medacta Group SA) has recorded 27 insider operations, including 10 open-market purchases ($2.2M), 17 sales ($7.0M). The insider sentiment is bearish (63% sales).
Insider activity at Medacta Group SA is sustained, with operations recorded in 8 of the last 12 months — a sign of regular regulatory filings.
Among the most active insiders are MEDAC (BOARD MEMBER), with respectively 27 transactions.
Across all 28 recorded transactions, the breakdown by type is: sales (18, 64%), buys (10, 36%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
Medacta Group SA has recorded 27 insider operations in total, including 10 open-market purchases ($2.2M), 17 sales ($7.0M). The most recent transaction was recorded on March 23, 2026.
Insiders at Medacta Group SA are currently net sellers, with 37% purchases and 63% sales across all reported transactions. Total buy volume is $2.2M versus $7.0M in sales, indicating a bearish insider sentiment.
InsiderLens tracks 1 insiders at Medacta Group SA (XSWX). MEDAC (BOARD MEMBER, 27 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for XSWX is bearish, based on a 37% buy ratio across 27 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for Medacta Group SA comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.